Psychotherapies for hypochondriasis

Thomson, Alex; Page, Lisa

doi:10.1002/14651858.cd006520.pub2

Cited by 86 publications

(79 citation statements)

References 64 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, hypochondriasis is more common in patients with psychiatric disorders, especially depression [13]. This underlying fear of illness may trigger a ''pain alarm,'' thus leading to both higher levels of attention by healthcare professionals and an increased use of resources [38]. In other words, depressed and anxious inpatients may feel less well for a given pathophysiology-ie, they may have less disease than the average inpatient with a similar illness.…”

Section: Discussionmentioning

confidence: 99%

Do Psychiatric Comorbidities Influence Inpatient Death, Adverse Events, and Discharge After Lower Extremity Fractures?

Menendez

Neuhaus

Bot

et al. 2013

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

Background Psychiatric comorbidity is known to contribute to illness (the state of feeling unwell/unable to rely on one's body) and increased use of healthcare resources, but the effect on inpatient outcomes in fracture care is relatively unexplored. Questions/purposes Our primary null hypothesis is that a concomitant diagnosis of depression, anxiety, dementia, or schizophrenia is not associated with (1) discharge to another care facility rather than home after lower extremity fractures. Secondary study questions address the associations between psychiatric comorbidity and (2) longer inpatient stay and inpatient (3) adverse events; (4) blood transfusion; and (5) mortality after lower extremity fractures. Methods Using the National Hospital Discharge Survey database, we analyzed a total estimated number of 10,669,449 patients with lower limb fractures from 1990 to 2007. Sixty-four percent were women, and the mean ± SD age was 67 ± 22 years. The prevalence in the study population was 3.2% for depression, 1.6% for anxiety, 0.6% for schizophrenia, and 2.9% for dementia. Results A discharge diagnosis of psychiatric comorbidity was associated with a lower rate of discharge to home after accounting for an association with greater medical comorbidity (schizophrenia: odds ratio [OR], 5.6, 95% confidence interval [CI], 5.5-5.8; dementia: OR, 1.3, 95% CI, 1.2-1.3; depression: OR, 1.2, 95% CI, 1.2-1.3; anxiety: OR, 1.04, 95% CI, 1.02-1.06). Hospital stay was longer for patients with schizophrenia and dementia but shorter in patients with depression or anxiety compared with patients without any mental disorders. Schizophrenia was associated with more in-hospital adverse events and depression and anxiety with fewer events. A diagnosis of depression was associated with blood transfusion. Psychiatric comorbidity was not associated with a higher risk of in-hospital death.

show abstract

Section: Discussionmentioning

confidence: 99%

Do Psychiatric Comorbidities Influence Inpatient Death, Adverse Events, and Discharge After Lower Extremity Fractures?

Menendez

Neuhaus

Bot

et al. 2013

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

show abstract

“…Pharmacological treatment is not normally acceptable to patients, as those with marked health anxiety are typically very sensitive to adverse effects of medication: but fluoxetine showed some benefit over placebo, though this was not pronounced and occurred late in treatment (8-12 weeks [I (PCT)] (Fallon et al, 2008). Psychological treatments have been found beneficial [I (M)] ( Thomson and Page, 2007), and include behavioural stress management (Clark et al, 1998) ([II]), cognitive behaviour therapy, in both face-to-face and internet format (Hedman et al, 2011b;Seivewright et al, 2008;Sørensen et al, 2011) (Tyrer et al, 2014).…”

Section: Marked Health Anxiety ('Illness Anxiety Disorder')mentioning

confidence: 99%

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

et al. 2014

View full text Add to dashboard Cite

This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and clinical management, including recognition, acute treatment, longer-term treatment, combination treatment, and further approaches for patients who have not responded to first-line interventions. A consensus meeting involving international experts in anxiety disorders reviewed the main subject areas and considered the strength of supporting evidence and its clinical implications. The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommendations to aid clinical decision-making in primary, secondary and tertiary medical care. They may also serve as a source of information for patients, their carers, and medicines management and formulary committees.

show abstract

“…Health anxiety is defined as anxiety about a health condition that only responds temporarily, if at all, to reassurance and is associated with some insight. Normal investigations may have the paradoxical effect of worsening the condition-there must be something if they need to do a scan they just haven t found it, yet A Cochrane review concluded that psychotherapy for health anxiety in general (hypochondriasis) showed significant improvement on average across studies [22]. When identified treatment of health anxiety is therefore often clinically rewarding.…”

Section: Health Anxiety About Dementiamentioning

confidence: 99%

Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic

Stone

Pal

Blackburn

et al. 2015

JAD

View full text Add to dashboard Cite

show abstract

Psychotherapies for hypochondriasis

Cited by 86 publications

References 64 publications

Do Psychiatric Comorbidities Influence Inpatient Death, Adverse Events, and Discharge After Lower Extremity Fractures?

Do Psychiatric Comorbidities Influence Inpatient Death, Adverse Events, and Discharge After Lower Extremity Fractures?

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic

Contact Info

Product

Resources

About